Literature DB >> 28824253

Modified Hyper-CVAD Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation Successfully Treated Synchronous T-Cell Prolymphocytic Leukemia and Gastric Cancer in a 68-Year-Old Female.

Guangquan Zhou1, Bai He1, Tongbing Chen2, Jiannong Cen3, Yang Cao1, Weiying Gu1.   

Abstract

Entities:  

Year:  2016        PMID： 28824253      PMCID： PMC5544643          DOI： 10.1007/s12288-016-0752-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  4 in total

1.  T-cell prolymphocytic leukemia in Japan: is it a variant?

Authors:  Junichi Kameoka; Naoto Takahashi; Hideyoshi Noji; Kazunori Murai; Katsushi Tajima; Yoshihiro Kameoka; Shinji Sato; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-04-24       Impact factor: 2.490

2.  Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.

Authors:  Biju Krishnan; Monica Else; Geir E Tjonnfjord; Bruno Cazin; Dennis Carney; John Carter; Nicolas Ketterer; Daniel Catovsky; Mark Ethell; Estella Matutes; Claire E Dearden
Journal:  Br J Haematol       Date:  2010-03-01       Impact factor: 6.998

3.  Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.

Authors:  Claire E Dearden; Amit Khot; Monica Else; Mike Hamblin; Effie Grand; Ashok Roy; Saman Hewamana; Estella Matutes; Daniel Catovsky
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

Review 4.  T-cell prolymphocytic leukemia.

Authors:  Claire E Dearden
Journal:  Clin Lymphoma Myeloma       Date:  2009
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.